Cannabis & Sperm Quality: What the Research Actually Shows | EP#431
Cannabis use negatively impacts male fertility through multiple mechanisms including reduced sperm production, quality, and motility, with a dose-response relationship where daily use is considered problematic. Partners of cannabis users experience higher miscarriage rates, and IVF outcomes show lower embryo development rates in men who use cannabis, though the speaker advocates for moderation rather than absolute prohibition.
Summary
The transcript discusses the multifaceted effects of cannabis on male reproductive health and fertility outcomes. A woman's question about why her doctor didn't advise her partner to quit smoking cannabis serves as the opening context. The speaker explains that while cannabis use negatively affects sperm, it doesn't necessarily prevent conception, as many people with poor habits still achieve pregnancy normally.
The effects of cannabis on fertility are described as multifaceted, impacting the brain, sperm production, sperm quality, and sperm motility. Beyond individual male fertility, the speaker notes that women whose partners use cannabis experience higher rates of miscarriage, even if the women themselves don't use the substance. From an IVF perspective, men who use cannabis show lower rates of embryo development.
Regarding the research landscape, the speaker acknowledges that literature on the topic contains somewhat contradictory data, but indicates a general consensus that cannabis is a negative factor for fertility. The speaker identifies a dose-response relationship, meaning that increased cannabis use correlates with worse outcomes. This dose-dependent effect leads the speaker to conclude that daily cannabis use is probably harmful.
In clinical counseling practice, the speaker attempts to understand patients' motivations for cannabis use. The speaker's guidance reflects a moderation-based approach rather than absolute abstinence, acknowledging that if daily use occurs, it's likely excessive. The speaker frames cannabis alongside other substances like alcohol, arguing that all substances affect the body negatively when taken to extremes, but occasional use for relaxation or pain management can be acceptable.
Key Insights
- Cannabis affects multiple aspects of male reproduction including the brain, sperm production, sperm quality, and sperm motility
- Women whose partners use cannabis have higher rates of miscarriage, regardless of whether the women themselves use cannabis
- Men who use cannabis show lower rates of embryo development when using IVF, despite sometimes contradictory literature on the topic
- There is a dose-response relationship where increased cannabis use correlates with worse reproductive outcomes
- The speaker counsels patients that daily cannabis use is probably excessive, but occasional use for relaxation or pain can be acceptable with proper moderation
Topics
Transcript
[0:00] One woman wrote, seemingly exasperated: “Why did n’t our doctor tell my partner to quit smoking cannabis?” Cannabis use negatively affects sperm. This does not mean that if someone uses it, they cannot get pregnant. There are people who have all sorts of bad habits, but still get pregnant normally. But if you look at the effects of cannabis, it is multifaceted. It affects the brain, sperm production, quality, motility , and pregnancy outcomes. Women whose partners use cannabis, even if they themselves don't, have higher rates of miscarriage because sperm is half the battle. And from an [0:30] IVF perspective, we see lower rates of embryo development in men who use cannabis. If you look at the literature,…
Full transcript available for MurmurCast members
Sign Up to AccessMore from The Proof with Simon Hill
Can You Actually Reverse Liver Scarring? [Expert Explains] | EP#436
Liver fibrosis and scarring, previously thought to be irreversible, can actually be reversed even in advanced stages of steatotic liver disease. The liver has enormous regenerative potential and can recover from significant damage caused by alcohol or obesity, offering hope that early intervention can restore normal liver function.
Why Lower ApoB Longer Reduces Heart Disease Risk? | T. Dayspring & D. Soffer | EP#430
ApoB is established as a driver of atherosclerosis based on multiple types of evidence including clinical trials, observational studies, and genetic data. Lower ApoB levels for longer periods reduce heart disease risk, with clinical evidence showing continued cardiovascular benefit even when LDL-C is reduced from 70 to 15 mg/dL.
Do You Really Need Surgery for a Shoulder Tear? | Howard Luks | EP#438
Most joint and tendon pain in adults stems from lack of support, training, and proper loading rather than injury. Imaging often reveals age-related changes like labral tears that are normal findings over age 40-45 and don't necessarily require surgery, despite what social media doctors claim.
MASH vs. MASLD: Which Medications Are Actually FDA Approved for Weight Loss? | Dr Mauricio Gonzalez
Dr. Mauricio Gonzalez clarifies that the United States has two FDA-approved medications specifically for MASH (metabolic dysfunction-associated steatohepatitis): resmetirom and semaglutide (Wegovy). However, for pure MASLD (metabolic dysfunction-associated fatty liver disease) without inflammation, there are currently no FDA-approved medications.
How Effective Are Weight Loss Drugs? The Risk and Limitations You Should Know About | EP#422
GLP-1 weight loss drugs are significantly more effective than diet alone, with 90-95% of clinical trial participants losing weight, but real-world non-response rates reach 20%. However, discontinuation rates are high (75% within 18 months), and without proper nutrition and exercise support, users risk losing up to 40% muscle mass while regaining primarily fat, creating sarcopenic obesity.